These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22510982)

  • 21. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes.
    Van Horn JT; Craven C; Ward K; Branch DW; Silver RM
    Placenta; 2004 Aug; 25(7):642-8. PubMed ID: 15193871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombosis of the terminal aorta, deep vein thrombosis, recurrent fetal loss, and antiphospholipid antibodies. Case report.
    Hohlfeld J; Schneider M; Hein R; Barthels M; von der Lieth H; Rosenthal H; Lang W; Alexander K
    Vasa; 1996; 25(2):194-9. PubMed ID: 8659225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome.
    Pierangeli SS; Vega-Ostertag M; Liu X; Girardi G
    Ann N Y Acad Sci; 2005 Jun; 1051():413-20. PubMed ID: 16126983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.
    Di Simone N; Meroni PL; D'Asta M; Di Nicuolo F; D'Alessio MC; Caruso A
    Hum Reprod Update; 2007; 13(2):189-96. PubMed ID: 17099207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function.
    Giles I; Lambrianides A; Rahman A
    Lupus; 2008 Oct; 17(10):895-903. PubMed ID: 18827054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpretation and recommended testing for antiphospholipid antibodies.
    Galli M
    Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome.
    Francis J; Rai R; Sebire NJ; El-Gaddal S; Fernandes MS; Jindal P; Lokugamage A; Regan L; Brosens JJ
    Mol Hum Reprod; 2006 Jul; 12(7):435-42. PubMed ID: 16735457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelets and the antiphospholipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
    Pierangeli SS; Vega-Ostertag ME; González EB
    Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome.
    Wijetilleka S; Scoble T; Khamashta M
    Curr Opin Rheumatol; 2012 Sep; 24(5):473-81. PubMed ID: 22585233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of thrombophilic genotypes is associated with definite antiphospholipid syndrome.
    Forastiero R; Martinuzzo M; Adamczuk Y; Varela ML; Pombo G; Carreras LO
    Haematologica; 2001 Jul; 86(7):735-41. PubMed ID: 11454529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
    Cervera R; Espinosa G
    Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
    Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
    Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies: effects on trophoblast and endothelial cells.
    D'Ippolito S; Di Simone N; Di Nicuolo F; Castellani R; Caruso A
    Am J Reprod Immunol; 2007 Aug; 58(2):150-8. PubMed ID: 17631008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis.
    López-Pedrera C; Cuadrado MJ; Herández V; Buendïa P; Aguirre MA; Barbarroja N; Torres LA; Villalba JM; Velasco F; Khamashta M
    Arthritis Rheum; 2008 Sep; 58(9):2835-44. PubMed ID: 18759277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.